Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications

Rupam Khatua, Bibrita Bhar, Souradeep Dey, Chitra Jaiswal, Victoria J and Biman B. Mandal

Nanoscale, 2024, 16, 12820
DOI: 10.1039/D4NR00680A

The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment

Wyatt M. Becicka, Peter A. Bielecki, Morgan E. Lorkowski, Taylor J. Moon, Yahan Zhang, Prabhani U. Atukorale, Gil Covarrubias and Efstathios Karathanasis

Nanoscale Adv., 2021, 3, 4961
DOI: 10.1039/D1NA00308A

Combination of cowpea mosaic virus (CPMV) intratumoral therapy and oxaliplatin chemotherapy

Miguel A. Moreno-Gonzalez, Zhongchao Zhao, Adam A. Caparco and Nicole F. Steinmetz

Mater. Adv., 2024, 5, 4878
DOI: 10.1039/D4MA00427B

Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment

Yulei Mu, Zhen Zhang, Huiqun Zhou, Liang Ma and Dong-An Wang

Biomater. Sci., 2024, 12, 4045
DOI: 10.1039/D4BM00665H

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation

Haonan Li, Qiang Luo, Hu Zhang, Xuelei Ma, Zhongwei Gu, Qiyong Gong and Kui Luo

Chem. Soc. Rev., 2023, 52, 47
DOI: 10.1039/D2CS00437B

Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer

Gil Covarrubias, Taylor J. Moon, Georgia Loutrianakis, Haley M. Sims, Mayura P. Umapathy, Morgan E. Lorkowski, Peter A. Bielecki, Michelle L. Wiese, Prabhani U. Atukorale and Efstathios Karathanasis

J. Mater. Chem. B, 2022, 10, 224
DOI: 10.1039/D1TB02256C

Hyperthermia-mediated changes in the tumor immune microenvironment using iron oxide nanoparticles

Gil Covarrubias, Morgan E. Lorkowski, Haley M. Sims, Georgia Loutrianakis, Abdelrahman Rahmy, Anthony Cha, Eric Abenojar, Sameera Wickramasinghe, Taylor J. Moon, Anna Cristina S. Samia and Efstathios Karathanasis

Nanoscale Adv., 2021, 3, 5890
DOI: 10.1039/D1NA00116G

Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumab

Adam Hermawan and Herwandhani Putri

Saudi Pharmaceutical Journal, 2021, 29, 1289
DOI: 10.1016/j.jsps.2021.09.015

Nanovaccine of tumor-derived antigenic microparticles for enhancing effect of arsenic trioxide in cancer immunotherapy

Shulei Zhang, Faisal Raza, Liangdi Jiang, Jing Su, Wei-En Yuan and Mingfeng Qiu

Nano Today, 2024, 57, 102321
DOI: 10.1016/j.nantod.2024.102321

cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma

Shashwat Tripathi, Hinda Najem, Akanksha Sanjay Mahajan, Peng Zhang, Justin T Low, Alexander H Stegh, Michael A Curran, David M Ashley, Charles David James and Amy B Heimberger

F1000Res, 2022, 11, 1010
DOI: 10.12688/f1000research.125163.1

Attenuated T cell activation and rearrangement of T cell receptor β repertoire in silica nanoparticle-induced pulmonary fibrosis of mice

Lei Bao, Zihan Geng, Juan Wang, Liyi He, Aijuan Kang, Jianshi Song, Xiaoyan Huang, Yaling Zhang, Qingping Liu, Tao Jiang, Yaxian Pang, Yujie Niu and Rong Zhang

Environmental Research, 2022, 213, 113678
DOI: 10.1016/j.envres.2022.113678

Emerging Nano‐Immunotherapeutic Approaches to Glioma

Jin Nan, Wei Yang, Yujie Xie, Meihua Yu, Yu Chen and Jun Zhang

Small Structures, 2023, 4
DOI: 10.1002/sstr.202300016

Nanoparticle-based drug delivery systems to modulate tumor immune response for glioblastoma treatment

Yongqi Xiong, Maoyuan Sun, Qinhao Yang, Wenli Zhang, Anchao Song, Ying Tan, Jinning Mao, Guodong Liu and Peng Xue

Acta Biomaterialia, 2025, 194, 38
DOI: 10.1016/j.actbio.2025.01.050

Single-cell transcriptomics reveals ferrimagnetic vortex iron oxide nanoring-mediated mild magnetic hyperthermia exerts antitumor effects by alleviating macrophage suppression in breast cancer

Pei Xi, Shihui Liu, Jiaxuan Tang, Xun Wang, Yongkang Liu, Xinxin Wang, Shuwei Hu, Kaixuan Wang, Wang Li, Zhiye Cai, Hailong Shi and Penggao Dai

Biomedicine & Pharmacotherapy, 2024, 170, 115954
DOI: 10.1016/j.biopha.2023.115954

Environment-friendly dual-mode immunoassay based on the inner filter effect of polydopamine-polyethylenimine copolymer nanoparticles for the highly sensitive detection of norfloxacin

Zizhe Li, Liang Luo, Chaochao Chen, Qiang Li, Qiyuan Zhao, Ghulam Mujtaba Mari, Chen Xing, Xuefeng Xia, Jianzhong Shen, XueZhi Yu, Zhanhui Wang and Yantong Pan

Food Chemistry, 2025, 480, 143928
DOI: 10.1016/j.foodchem.2025.143928

Targeting immunosuppressive network in glioblastoma: Emerging strategies to overcome immunodeficiency and enhance therapeutic efficacy

Songlei Zhou, Xiaokun Zhang, Jiayi Lin, Fenfen Ma, Hongzhuan Chen, Jun Chen and Xin Luan

Acta Pharmaceutica Sinica B, 2026, 16, 1272
DOI: 10.1016/j.apsb.2026.01.015

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan and Yaping Chen

Advanced Therapeutics, 2025, 8
DOI: 10.1002/adtp.202500124

Lipidic and Inorganic Nanoparticles for Targeted Glioblastoma Multiforme Therapy: Advances and Strategies

Ewelina Musielak and Violetta Krajka-Kuźniak

Micro, 2025, 5, 2
DOI: 10.3390/micro5010002

Nanoparticle-Based Treatment in Glioblastoma

Diogo Roque, Nuno Cruz, Hugo Alexandre Ferreira, Catarina Pinto Reis, Nuno Matela, Manuel Herculano-Carvalho, Rita Cascão and Claudia C. Faria

JPM, 2023, 13, 1328
DOI: 10.3390/jpm13091328

Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders

Dhananjay Bhatane, Sharon Rose Pamshong, Santosh Sarnaik, Prabakaran A and Amit Alexander

Journal of Drug Delivery Science and Technology, 2023, 89, 104970
DOI: 10.1016/j.jddst.2023.104970

Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

Jennifer K. Matsui, Haley K. Perlow, Rohit K. Raj, Ansel P. Nalin, Eric J. Lehrer, Rupesh Kotecha, Daniel M. Trifiletti, Shearwood McClelland, Kari Kendra, Nicole Williams, Dwight H. Owen, Carolyn J. Presley, Evan M. Thomas, Sasha J. Beyer, Dukagjin M. Blakaj, Manmeet S. Ahluwalia, Raju R. Raval and Joshua D. Palmer

Biomedicines, 2022, 10, 2211
DOI: 10.3390/biomedicines10092211

Engineering approaches for innate immune-mediated tumor microenvironment remodeling

G.I. Kane, C.F. Lusi, M.L. Brassil and P.U. Atukorale

Immuno-Oncology and Technology, 2024, 21, 100406
DOI: 10.1016/j.iotech.2023.100406

Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma

Songlei Zhou, Yukun Huang, Yu Chen, Yipu Liu, Laozhi Xie, Yang You, Shiqiang Tong, Jianpei Xu, Gan Jiang, Qingxiang Song, Ni Mei, Fenfen Ma, Xiaoling Gao, Hongzhuan Chen and Jun Chen

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-35957-8

Receptor agonist/antagonist-incorporated anticancer nanodrugs: Design, materials, and strategies

Shi-Jie Hao, Shun-Yu Wu, Yun-Kai Chang and Fu-Gen Wu

Materials Today, 2025, 82, 181
DOI: 10.1016/j.mattod.2024.11.006

Comparison of nose-to-brain and systemic delivery of STING agonist-loaded liposomes for glioblastoma treatment

Mustafa Kotmakci, Busra Bara, Zafer Yildirim, Ezgi Oner, Banu Yaman, Taner Akalin, Erkin Ozgiray, Buket Kosova and Vildan Bozok

Journal of Drug Delivery Science and Technology, 2025, 109, 107000
DOI: 10.1016/j.jddst.2025.107000

Advancements in nanotheranostics for glioma therapy

Liza Sahoo, Safal Kumar Paikray, Nigam Sekhar Tripathy, Donald Fernandes and Fahima Dilnawaz

Naunyn-Schmiedeberg's Arch Pharmacol, 2025, 398, 2587
DOI: 10.1007/s00210-024-03559-w

Harnessing cGAS‐STING Pathway for Cancer Immunotherapy: From Bench to Clinic

DaeYong Lee, Kristin Huntoon, Minjeong Kang, Yifei Lu, Thomas Gallup, Wen Jiang and Betty Y. S. Kim

Advanced Therapeutics, 2022, 5
DOI: 10.1002/adtp.202200040

Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy

Shuang Liang, Jianjun Yao, Dan Liu, Mengli Zhou, Yong Cui and Zhaohui Wang

Chinese Chemical Letters, 2025, 36, 109856
DOI: 10.1016/j.cclet.2024.109856

Small Particles, Big Impact: Inorganic Nanotechnology for Glioblastoma

Klaudia Dynarowicz, David Aebisher, Jakub Tylutki, Nazarii Kozak, Aleksandra Kawczyk-Krupka and Dorota Bartusik-Aebisher

Molecules, 2026, 31, 565
DOI: 10.3390/molecules31030565

Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.

Varsha Godakhindi, Mubin Tarannum, Sudip Kumar Dam and Juan L. Vivero‐Escoto

Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202400323

Targeting glioblastoma through nano- and micro-particle-mediated immune modulation

Ellen Poot, Ander Maguregui, Valerie G. Brunton, Dirk Sieger and Alison N. Hulme

Bioorganic & Medicinal Chemistry, 2022, 72, 116913
DOI: 10.1016/j.bmc.2022.116913

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

Xi Chen, Zhijie Xu, Tongfei Li, Abhimanyu Thakur, Yu Wen, Kui Zhang, Yuanhong Liu, Qiuju Liang, Wangrui Liu, Jiang-Jiang Qin and Yuanliang Yan

Biomark Res, 2024, 12
DOI: 10.1186/s40364-023-00551-z

Delivery of STING agonists for adjuvanting subunit vaccines

Simon Van Herck, Bing Feng and Li Tang

Advanced Drug Delivery Reviews, 2021, 179, 114020
DOI: 10.1016/j.addr.2021.114020

STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications

Cheng Xu, Hannah E. Dobson, Mengjie Yu, Wang Gong, Xiaoqi Sun, Kyung Soo Park, Andrew Kennedy, Xingwu Zhou, Jin Xu, Yao Xu, Andrew W. Tai, Yu Leo Lei and James J. Moon

Journal of Controlled Release, 2023, 357, 84
DOI: 10.1016/j.jconrel.2023.03.036

Stimuli-responsive nanoplatforms for precision activation of the STING pathway in cancer immunotherapy

Dongming Bi, Xue Yang, Yuan Wang, Jiangyan Yong, Fujie Yang, Xiaoyu Tan, Yuchen Li, Dongming Zheng and Pandeng Li

Front. Immunol., 2026, 17
DOI: 10.3389/fimmu.2026.1714249

Silica nanoparticles: Biomedical applications and toxicity

Yanmei Huang, Peng Li, Ruikang Zhao, Laien Zhao, Jia Liu, Shengjun Peng, Xiaoxuan Fu, Xiaojie Wang, Rongrui Luo, Rong Wang and Zhuhong Zhang

Biomedicine & Pharmacotherapy, 2022, 151, 113053
DOI: 10.1016/j.biopha.2022.113053

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma

Han Wu, Xin-Fei Xu, Jia-Qi Zhu, Ming-Da Wang, Chao Li, Lei Liang, Hao Xing, Meng-Chao Wu, Feng Shen, Dong-Sheng Huang and Tian Yang

Front. Bioeng. Biotechnol., 2021, 9
DOI: 10.3389/fbioe.2021.695635

Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

Zahra Fekrirad, Amir Barzegar Behrooz, Shokoofeh Ghaemi, Arezou Khosrojerdi, Atefeh Zarepour, Ali Zarrabi, Ehsan Arefian and Saeid Ghavami

Cancers, 2022, 14, 3698
DOI: 10.3390/cancers14153698

Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders

Matteo Battaglini, Attilio Marino, Margherita Montorsi, Alessio Carmignani, Maria Cristina Ceccarelli and Gianni Ciofani

Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202304180

Nanocarriers in glioblastoma treatment: a neuroimmunological perspective

Faezeh Firuzpour, Kiarash Saleki, Cena Aram and Nima Rezaei

Reviews in the Neurosciences, 2025, 36, 431
DOI: 10.1515/revneuro-2024-0097

Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours

Eda Dogan, Zafer Yildirim, Taner Akalin, Erkin Ozgiray, Nevhis Akinturk, Cagdas Aktan, Asli Ece Solmaz, Huseyin Biceroglu, Kadri Emre Caliskan, Yesim Ertan, Taskin Yurtseven, Buket Kosova and Vildan Bozok

J Neurooncol, 2024, 166, 283
DOI: 10.1007/s11060-023-04556-4

The STING Signaling: A Novel Target for Central Nervous System Diseases

Min Song, Jianxun Ren, Zhipeng Zhu, Zhaohui Yi, Chengyun Wang, Lirong Liang, Jiahui Tian, Guofu Mao, Guohua Mao and Min Chen

Cell Mol Neurobiol, 2025, 45
DOI: 10.1007/s10571-025-01550-4

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy

Kyle M. Garland, Taylor L. Sheehy and John T. Wilson

Chem. Rev., 2022, 122, 5977
DOI: 10.1021/acs.chemrev.1c00750

Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy

Jun-Long Liang, Xiao-Kang Jin, Xin-Chen Deng, Qian-Xiao Huang, Shi-Man Zhang, Wei-Hai Chen and Xian-Zheng Zhang

Materials Today, 2024, 78, 251
DOI: 10.1016/j.mattod.2024.07.004

The Glymphatic–Immune Axis in Glioblastoma: Mechanistic Insights and Translational Opportunities

Joaquin Fiallo Arroyo and Jose E. Leon-Rojas

IJMS, 2026, 27, 928
DOI: 10.3390/ijms27020928

The blood–brain barrier: Structure, regulation and drug delivery

Di Wu, Qi Chen, Xiaojie Chen, Feng Han, Zhong Chen and Yi Wang

Sig Transduct Target Ther, 2023, 8
DOI: 10.1038/s41392-023-01481-w

The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development

Hongbin Yan and Wangxue Chen

Vaccines, 2021, 9, 917
DOI: 10.3390/vaccines9080917

STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges

Kun Yang, Zhen Tang, Cong Xing and Nan Yan

Neuron, 2024, 112, 539
DOI: 10.1016/j.neuron.2023.10.014

Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment

Sai Kiran S. S. Pindiprolu, Madhu Tanya Singh, Sai Varshini Magham, Chirravuri S. Phani Kumar, Nagasen Dasari, Ramakrishna Gummadi and Praveen Thaggikuppe Krishnamurthy

Naunyn-Schmiedeberg's Arch Pharmacol, 2025, 398, 7667
DOI: 10.1007/s00210-025-03835-3

Mesoporous Silica: A Promising Adjuvant for Cancer Vaccines

Xiupeng Wang

Small, 2026, 22
DOI: 10.1002/smll.202507547